Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring

AIMS: To explore the effects of dapagliflozin on congestion through CardioMEMS (Abbott Inc., Atlanta, USA) and Cordella™ pulmonary artery Sensor (Endotronix Inc., Lisle, Il, USA) devices, which are implantable systems that provide real‐time remote monitoring of pulmonary artery pressure (PAP). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullens, Wilfried, Martens, Pieter, Forouzan, Omid, Dauw, Jeroen, Vercammen, Jan, Luwel, Evert, Ceyssens, Wendy, Kockaerts, Veerle, Ameloot, Koen, Dupont, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524114/
https://www.ncbi.nlm.nih.gov/pubmed/32588973
http://dx.doi.org/10.1002/ehf2.12850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524114/
https://www.ncbi.nlm.nih.gov/pubmed/32588973
http://dx.doi.org/10.1002/ehf2.12850

Ejemplares similares